Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

• Status: Completed
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare bleeding pattern of contraceptive Yasmin 20 to a marketed comparator.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Dacuronium; Drospirenone and ethinyl estradiol combination; Pancuronium

Criteria

Inclusion Criteria:

• Healthy female volunteer aged 18-35,

• Smokers 18-30

Exclusion Criteria:

• Contraindications for using hormonal contraceptives